Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal methylene blue injection for discogenic low back pain
2010-022025-15Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylene blue in discogenic back pain (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Mean pain NRS at 6 months, Highest NRS back pain at 6 months and 2 more. Started Jul 2010; status: completed.
02
Drugs
methylene blue
03
Conditions
discogenic back pain
Beyond the preview
Go deeper on 2010-022025-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022025-15.